SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-047805
Filing Date
2024-11-26
Accepted
2024-11-26 16:11:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 77978
  Complete submission text file 0001493152-24-047805.txt   79423
Mailing Address 740 BROADWAY 9TH FLOOR NEW YORK NY 10003
Business Address
Meckler Jeffrey A (Filed by) CIK: 0001506916 (see all company filings)

Type: SC 13D/A

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Subject) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92776 | Film No.: 241503819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)